A federal judge in Virginia has ruled that FDA restrictions on the abortion medication mifepristone are arbitrary and capricious, ordering a review of the current regulations.
Key facts
- •Judge Robert S. Ballou ruled that FDA restrictions on mifepristone are arbitrary and capricious.
- •The lawsuit, Whole Woman’s Health Alliance v. FDA, was filed in May 2023 by the Center for Reproductive Rights.
- •Plaintiffs represent abortion providers operating in Virginia, Kansas, and Montana.
- •Mifepristone accounts for nearly two-thirds of all abortions currently performed in the United States.
- •The FDA is currently conducting a review of abortion pill regulations as requested by conservative lawmakers and activists.
US District Judge Robert S. Ballou ordered the Food and Drug Administration on Friday to reconsider existing restrictions on the abortion medication mifepristone. In his ruling, the judge determined that the current regulations are arbitrary and capricious, noting that previous FDA reviews have consistently found the drug to be both safe and effective. The decision comes as part of the ongoing case Whole Woman’s Health Alliance v. FDA, which was filed in May 2023.
Legal Challenge and Court Findings
The lawsuit, brought by the Center for Reproductive Rights on behalf of abortion providers in Virginia, Kansas, and Montana, challenged three specific requirements for prescribing and dispensing mifepristone. Plaintiffs argued that these mandates, which include special registration for providers and pharmacies as well as additional patient paperwork, are medically unnecessary. The court’s findings align with decades of clinical and scientific research regarding the drug's safety profile.
Broader Context of Abortion Access
While this ruling addresses the current regulatory framework, the legal landscape remains divided. A separate case involving the state of Louisiana is currently before the Fifth Circuit, where arguments are being heard regarding a request to reinstate restrictions that would limit pharmacy prescriptions and block mail-order access to the drug. Meanwhile, abortion pills now account for nearly two-thirds of all abortions performed in the United States.
Advertisement
This article was independently rewritten by ManyPress editorial AI from reporting originally published by The Guardian Health.
